Prostate-specific Antigen Testing Market
Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: ... Read More
Prostate Specific Antigen (PSA) Blood Based Biomarker Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) BLOOD BASED BIOMARKER INDUSTRY
2.1 Summary about Prostate Specific Antigen (PSA) Blood Based Biomarker Industry
2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Market Trends
2.2.1 Prostate Specific Antigen (PSA) Blood Based Biomarker Production & Consumption Trends
2.2.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Demand Structure Trends
2.3 Prostate Specific Antigen (PSA) Blood Based Biomarker Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Screening Biomarker
4.2.2 Diagnosis Biomarker
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Diagnostics
4.3.2 Drug Discovery
4.3.3 Personalized Medicine
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Screening Biomarker
5.2.2 Diagnosis Biomarker
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Diagnostics
5.3.2 Drug Discovery
5.3.3 Personalized Medicine
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Screening Biomarker
6.2.2 Diagnosis Biomarker
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Diagnostics
6.3.2 Drug Discovery
6.3.3 Personalized Medicine
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Screening Biomarker
7.2.2 Diagnosis Biomarker
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Diagnostics
7.3.2 Drug Discovery
7.3.3 Personalized Medicine
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Screening Biomarker
8.2.2 Diagnosis Biomarker
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Diagnostics
8.3.2 Drug Discovery
8.3.3 Personalized Medicine
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Screening Biomarker
9.2.2 Diagnosis Biomarker
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Diagnostics
9.3.2 Drug Discovery
9.3.3 Personalized Medicine
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 ProteoMediX
10.1.2 Cleveland Diagnostics
10.1.3 Randox
10.1.4 Roche
10.1.5 GENFIT
10.1.6 Nutech Cancer Biomarkers
10.1.7 OGT (Sysmex Group)
10.1.8 Minomic
10.1.9 Creative Diagnostics
10.2 Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Date of Major Players (2017-2020e)
10.2.1 ProteoMediX
10.2.2 Cleveland Diagnostics
10.2.3 Randox
10.2.4 Roche
10.2.5 GENFIT
10.2.6 Nutech Cancer Biomarkers
10.2.7 OGT (Sysmex Group)
10.2.8 Minomic
10.2.9 Creative Diagnostics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table 1.Table Prostate Specific Antigen (PSA) Blood Based Biomarker Product Type Overview 2.Table Prostate Specific Antigen (PSA) Blood Based Biomarker Product Type Market Share List 3.Table Prostate Specific Antigen (PSA) Blood Based Biomarker Product Type of Major Players 4.Table Brief Introduction of ProteoMediX 5.Table Brief Introduction of Cleveland Diagnostics 6.Table Brief Introduction of Randox 7.Table Brief Introduction of Roche 8.Table Brief Introduction of GENFIT 9.Table Brief Introduction of Nutech Cancer Biomarkers 10.Table Brief Introduction of OGT (Sysmex Group) 11.Table Brief Introduction of Minomic 12.Table Brief Introduction of Creative Diagnostics 13.Table Products & Services of ProteoMediX 14.Table Products & Services of Cleveland Diagnostics 15.Table Products & Services of Randox 16.Table Products & Services of Roche 17.Table Products & Services of GENFIT 18.Table Products & Services of Nutech Cancer Biomarkers 19.Table Products & Services of OGT (Sysmex Group) 20.Table Products & Services of Minomic 21.Table Products & Services of Creative Diagnostics 22.Table Market Distribution of Major Players 23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 25.Table Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast (Million USD) by Region 2021f-2026f 26.Table Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast (Million USD) Share by Region 2021f-2026f 27.Table Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast (Million USD) by Demand 2021f-2026f 28.Table Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure 1.Figure Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Size under the Impact of COVID-19, 2017-2021f (USD Million) 2.Figure Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Region under the Impact of COVID-19, 2017-2021f (USD Million) 3.Figure Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million) 4.Figure Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million) 5.Figure Global Prostate Specific Antigen (PSA) Blood Based Biomarker Production by Region under the Impact of COVID-19, 2021-2026 (USD Million) 6.Figure Global Prostate Specific Antigen (PSA) Blood Based Biomarker Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million) 7.Figure Global Prostate Specific Antigen (PSA) Blood Based Biomarker Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million) 8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 13.Figure Screening Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 14.Figure Diagnosis Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 15.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 16.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 17.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 22.Figure Screening Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 23.Figure Diagnosis Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 24.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 25.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 26.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 33.Figure Screening Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 34.Figure Diagnosis Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 35.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 36.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 37.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 46.Figure Screening Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 47.Figure Diagnosis Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 48.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 49.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 50.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 55.Figure Screening Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 56.Figure Diagnosis Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 57.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 58.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 59.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 65.Figure Screening Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 66.Figure Diagnosis Biomarker Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 67.Figure Diagnostics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 68.Figure Drug Discovery Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 69.Figure Personalized Medicine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 71.Figure Prostate Specific Antigen (PSA) Blood Based Biomarker Sales Revenue (Million USD) of ProteoMediX 2017-2020e 72.Figure Prostate Specific Antigen (